Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - - - - - - 67.05M
2.71%2.82%71.16x5.96x5.13x21.1x28.44x 305B
1.67%1.74%23.66x1.98x3.25x11.59x19.13x 69.44B
2.6%2.78%17.16x1.48x2.18x7.5x8.95x 8.56B
-.--%-.--%21.98x5.85x6.24x17.65x18.45x 4.3B
0.81%0.82%38.03x2.27x2.15x26.5x40x 3.4B
-.--%-.--%108.9x - - - - 2.81B
4.15%3.58%17.06x0.75x1.33x23.78x40.71x 1.05B
-.--%-.--%-7.43x12.24x203.85x-6.61x-5.15x 965M
Average 1.49% 1.47% 36.32x 4.36x 32.02x 14.50x 21.50x 43.97B
Weighted average by Cap. 2.46% 2.55% 60.77x 5.13x 5.20x 19.07x 26.31x
Specialty & Advanced Pharmaceuticals